As IL-4/IL-13 treatment of epidermal equivalents based on N/TERT-1 cells can induce histopathological and molecular hallmarks of atopic dermatitis (19), we investigated whether the cytokine-induced barrier alterations enhance HSV-1 invasion. Here, IL13 is linked to atopic eczema.